A Study of Anti-HIV Compounds which Interfere the Virus Entry via Coreceptor CXCR4
-
- KANBARA Kenji
- Department of Microbiology and Immunology, Kagoshima University Dental School
-
- FUJII Nobutaka
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- NAKASHIMA Hideki
- Department of Microbiology and Immunology, Kagoshima University Dental School
Bibliographic Information
- Other Title
-
- HIV感染のコレセプター, CXCR4, を標的とした抗HIV薬の開発
- 第73回 日本感染症学会総会 学術講演会座長 推薦論文 HIV感染のコレセプター,CXCR4,を標的とした抗HIV薬の開発
- ダイ73カイ ニホン カンセンショウ ガッカイ ソウカイ ガクジュツ コウエンカイ ザチョウ スイセン ロンブン HIV カンセン ノ コレセプター CXCR4 オ ヒョウテキ ト シタ コウHIVヤク ノ カイハツ
Search this article
Abstract
T22 is an anti-HIV polypeptide which was synthesized with chemical modification from the horse shoe hemocytic polypeptides, polyphemusin II as a lead compound. T22 was found to block Ttropic HIV-1 entry into target cells as a CXCR4 antagonist. We synthesized T134, a small sized analog of T22 with reduced positive charges. T134 exhibited highly potent activity and significantly less cytotoxicity when compared to T22. It was shown that bicyclam AMD3100 and ALX40-4C are antagonists of CXCR4, and vMIP II which is coded chemokine in HHV8/ICSHV effects antagonistically both CXCR4 and CCR5. We examined the anti-HIV activity of these CXCR4 antagonists. All of them inhibit the binding of anti-CXCR4 antibody (12G5) to PBMC, but have no effect on the binding of anti-CCR5 antibody (2D7) except for vMIP II. vMIP II decreased the binding of both 12G5 and 2D7. In these compounds, T134 showed the most potency to anti-HIV activity. We also attempted to clarify the cross resistance between these antagonists, using HIV-1 resistant to AMD3100. T134, ALX40-4C and vMIP II are active against the AMD3100 resistant strain. This observation indicates the potential of using these the inhibitors as a new type of agent preventing HIV entry.
Journal
-
- Kansenshogaku Zasshi
-
Kansenshogaku Zasshi 74 (3), 237-244, 2000
The Japanese Association for Infectious Diseases
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205050101760
-
- NII Article ID
- 130004330857
- 10008706803
-
- NII Book ID
- AN00047715
-
- ISSN
- 1884569X
- 03875911
-
- NDL BIB ID
- 5332403
-
- PubMed
- 10783578
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed